Inveready invests 4.5 million euros in Devon Labs
Inveready, Spain's leading venture capital firm, has made a 4.5 million euro investment in Devon Labs through its Inveready Biotech III and Inveready Venture Finance III funds.
Barcelona, july 6, 2025
Inveready, Spain’s leading venture capital firm, has made a 4.5-million-euro investment in Devon Labs through its Inveready Biotech III and Inveready Venture Finance III funds.
The investment will drive the company’s national growth by expanding its commercial area, acquiring, and exclusively launching new products in the fields of oncology, pain, and the central nervous system (CNS). To complement its range of medicines and medical devices, Devon Labs is engaged in developing a series of digital telemedicine/support tools that offer support to patients and caregivers, complementing conventional pharmacological treatment.
06/06/2022
Inveready invests 4.5 million euros in Devon Labs
Inveready, Spain's leading venture capital firm, has made a 4.5 million euro investment in Devon Labs through its Inveready Biotech III and Inveready Venture Finance III funds.